Total Funding
42
66
Total FundingSeed raised
Growth Score 42 in past quarter
-1 pts
Heat Score 66 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
138219
Innosphere is a wearable medical device that treats ADHD without side effects.
- Past Role: Optretina, International Development and Founder
- Rami Shacour: CEO & Co-founderPast Role: Rami Shacour & Co., Founder and managing partner
About the Company
Innosphere is a wearable medical device that treats ADHD without side effects. With its patented technologies, and in collaboration with Yale University and the University of Oxford, InnosSphere has achieved significant clinical results and alleviates ADHD symptoms in clinical trials at Hadassah Medical Center in Jerusalem and at King’s College of
London. They offer hope for long-term improvement in the quality of life of millions of patients.
InnoSphere technology is based on recent collaborative research conducted with leading worldwide institutes and universities in the field of cognitive neuroscience.
InnoSphere was founded by Gilad Israeli in 2016.